A recall of Nara brand infant formula has been initiated following suspicions of botulism contamination, prompting a response from Taiwan’s Food and Drug Administration (FDA). The FDA confirmed they were notified by the U.S. Food and Drug Administration regarding potential contamination issues. Initial investigations suggest the contamination may stem from a raw material supplier. The recall affects specific batches of the formula, and consumers are advised to discontinue use immediately. Taiwan’s FDA is conducting further testing and investigations to determine the extent of the contamination and ensure consumer safety. Authorities are working to trace the source of the issue and prevent further distribution of affected products, emphasizing a commitment to public health.